Last updated on 18 May 2023
Owner Info
APIRx Pharmaceutical USA, LLC Limited Liability Company (Delaware)
18 E. 50th Street
5th Fl., Suite B, New York, New York, 10022 UNITED STATES OF AMERICA
Serial Number
2213413 filed on 23 Sept 2021
Correspondent
Davies Collison Cave Pty Ltd
Level 4,
7 Macquarie Place,
Sydney, NSW, 2000 AUSTRALIA
2213413
23 Sept 2021
23 Sept 2031
WORD
22 Sept 2021
US
Status Date | Action Taken |
---|---|
18th May 2023 | Customer Amendment Made correspondence sent |
18th May 2023 | Customer Amendment Made correspondence sent |
18th May 2023 | Amendment to Address for Service Requested |
3rd May 2022 | IP Right Registered correspondence sent |
3rd May 2022 | IP Right Registration Published |
3rd May 2022 | Status change to Registered/Protected |
23rd Feb 2022 | Application Accepted correspondence sent |
23rd Feb 2022 | IP Right has been Examined |
23rd Feb 2022 | IP Right Acceptance Published |
11th Oct 2021 | Early Acceptance Notice correspondence sent |